Tonix Pharmaceuticals HoldinTNXP
13F holders, Q2 2026 (June 30)1holders −1
1new positions
0sold out
$11.97avg. 13F price*
At the end of Q2 2026, 1 institutions reported holding Tonix Pharmaceuticals Holdin (TNXP) in their 13F filings, down 1 from Q2 2024. 1 opened new positions and 0 sold out. The largest holder was RMG Wealth Management LLC ($1K).
- Company
- Tonix Pharmaceuticals Holdin
- CUSIP
- 890260854
- Latest filing quarter
- Q2 2026
History
Number of 13F holders
Total Exit/New Position Q2 2024 → Q2 2026
| Institutions | Total Value | |
|---|---|---|
| New Positions | 1 | $1K |
| Exits | 0 | $0 |
All 13F filers, Q2 2024 → Q2 2026: 100 shares bought, net +100 shares. Counts holders who added, trimmed, opened or closed a position; split-adjusted.
Ownership 1 holders
| RMG Wealth Management LLC | 0.00% | New | 100 | $1K |
"% of holder's portfolio" is TNXP's weight in each manager's 13F, not the share of Tonix Pharmaceuticals Holdin the manager owns.